Specifically, recent studies confirm that IRF4 upregulation following T cell activation impedes human CD8 T cell effector function, while promoting cell proliferation and PD-1 expression, contributing to an exhausted phenotype in tumor-infiltrating lymphocytes (TILs) rather than activation alone 45. Here, IRF4 is linked to neoplasm.